Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
14,423,417
-
Total 13F shares
-
8,933,638
-
Share change
-
+8,504
-
Total reported value
-
$340,637,222
-
Put/Call ratio
-
59%
-
Price per share
-
$38.16
-
Number of holders
-
147
-
Value change
-
+$325,932
-
Number of buys
-
3
-
Number of sells
-
3
Institutional Holders of Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) as of Q4 2013
As of 31 Dec 2013,
Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) was held by
147 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,933,638 shares.
The largest 10 holders included
DIMENSIONAL FUND ADVISORS LP, BlackRock Fund Advisors, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Institutional Trust Company, N.A., Allianz Asset Management AG, PERRITT CAPITAL MANAGEMENT INC, State Street Corp, ACADIAN ASSET MANAGEMENT LLC, and BOGLE INVESTMENT MANAGEMENT L P /DE/.
This page lists
147
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.